Arrowhead Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04280A1007

SecurityARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership98,194 shares
Latest Disclosed Value $ 6,156,764
Citadel Advisors Llc ownership in ARWR / Arrowhead Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 98,194 shares of Arrowhead Pharmaceuticals, Inc. (US:ARWR) valued at $6,156,764 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 474,259 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of -79.30% during the quarter. The current value of the position is $7,176,999 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ARWR) in the form of stock options. The firm currently holds call options representing 187,000 of underlying shares valued at $11,724,900 USD and put options representing 65,300 of underlying shares valued at $4,094,310 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARWR / Arrowhead Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 98,194 -376,065 -79.30 6,157 -80.45 0.0010
2026-02-17 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 474,259 156,645 49.32 31,486 187.44 0.0047
2025-11-14 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 317,614 255,369 410.26 10,955 1,014.34 0.0017
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 62,245 -924,706 -93.69 983 -92.18 0.0002
2025-05-15 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 986,951 618,953 168.19 12,574 81.74 0.0024
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 367,998 -809,579 -68.75 6,918 -69.67 0.0012
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 1,177,577 229,133 24.16 22,810 -7.47 0.0044
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 948,444 206,547 27.84 24,650 16.17 0.0050
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 741,897 683,260 1,165.24 21,218 1,082.72 0.0041
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 58,637 -80,634 -57.90 1,794 -52.06 0.0004
2023-11-14 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 139,271 -454,761 -76.55 3,742 -82.33 0.0008
2023-08-14 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 594,032 -254,273 -29.97 21,183 -1.68 0.0044
2023-05-15 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 848,305 204,332 31.73 21,547 -17.51 0.0047
2023-02-14 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 643,973 90,425 16.34 26,120 42.77 0.0061
2022-11-14 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 553,548 179,851 48.13 18,295 39.04 0.0042
2022-08-15 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 373,697 173,773 86.92 13,158 43.12 0.0034
2022-05-16 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 199,924 136,629 215.86 9,194 119.11 0.0019
2022-02-14 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 63,295 -29,868 -32.06 4,196 -27.85 0.0009
2021-11-15 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 93,163 -121,825 -56.67 5,816 -67.34 0.0012
2021-08-16 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 214,988 -192,675 -47.26 17,805 -34.13 0.0040
2021-05-21 2021-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 407,663 106,791 35.49 27,032 17.09 0.0066
2021-05-17 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 407,663 106,791 27,032 0.0066
2021-02-16 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 300,872 34,890 13.12 23,086 101.57 0.0060
2020-11-16 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 265,982 145,752 121.23 11,453 120.55 0.0032
2020-08-14 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 120,230 -26,972 -18.32 5,193 22.62 0.0019
2020-05-15 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 147,202 -805 -0.54 4,235 -54.89 0.0019
2020-02-14 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 148,007 86,113 139.13 9,388 438.30 0.0041
2019-11-14 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 61,894 46,256 295.79 1,744 321.26 0.0008
2019-08-14 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 15,638 -59,095 -79.07 414 -69.83 0.0002
2019-05-15 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 74,733 -20,080 -21.18 1,372 16.47 0.0007
2019-02-14 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 94,813 -7,499 -7.33 1,178 -39.93 0.0006
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 102,312 -498,682 -82.98 1,961 -76.01 0.0009
2018-08-14 2018-06-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 600,994 575,955 2,300.23 8,173 4,415.47 0.0040
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 600,994 575,955 8,173
2018-05-14 2018-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 25,039 -17,870 -41.65 181 14.56 0.0001
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 25,039 -17,870 181
2018-02-09 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 42,909 14,557 51.34 158 28.46 0.0001
2017-11-09 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 28,352 28,352 123 0.0001
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS Cmn 04280A100 0 -14,739 -100.00 0 -100.00
2017-01-31 2016-06-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN Cmn 04280A100 14,739 14,739 78 0.0001
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS Cmn 04280A100 14,739 78 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 187,000 -20.12 11,725 -24.56 n/a n/a n/a
2026-02-17 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 234,100 85.94 15,542 257.92 n/a n/a n/a
2025-11-14 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 125,900 74.14 4,342 280.21 n/a n/a n/a
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 72,300 81.66 1,142 125.25 n/a n/a n/a
2025-05-15 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 39,800 -18.11 507 -44.47 n/a n/a n/a
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 48,600 30.29 914 26.45 n/a n/a n/a
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 37,300 -19.44 723 -39.98 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 46,300 123.67 1,203 103.21 n/a n/a n/a
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 20,700 -73.32 592 -75.06 n/a n/a n/a
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 77,600 18.29 2,375 34.73 n/a n/a n/a
2023-11-14 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 65,600 40.77 1,763 6.08 n/a n/a n/a
2023-08-14 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 46,600 -25.80 1,662 4.14 n/a n/a n/a
2023-05-15 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 62,800 -42.81 1,595 -64.18 n/a n/a n/a
2023-02-14 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 109,800 -26.41 4,453 -9.69 n/a n/a n/a
2022-11-14 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 149,200 22.50 4,931 14.97 n/a n/a n/a
2022-08-15 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 121,800 -29.39 4,289 -45.93 n/a n/a n/a
2022-05-16 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 172,500 -33.88 7,933 -54.14 n/a n/a n/a
2022-02-14 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 260,900 19.08 17,298 26.47 n/a n/a n/a
2021-11-15 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 219,100 16.48 13,678 -12.20 n/a n/a n/a
2021-08-16 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 188,100 19.43 15,578 49.16 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Call 157,500 -32.95 10,444 -42.06 n/a n/a n/a
2021-05-17 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 157,500 10,444 n/a n/a n/a
2021-02-16 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Call 234,900 18.10 18,024 110.44 n/a n/a n/a
2020-11-16 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Call 198,900 -3.40 8,565 -3.69 n/a n/a n/a
2020-08-14 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 205,900 19.71 8,893 79.73 n/a n/a n/a
2020-05-15 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 172,000 -8.85 4,948 -58.66 n/a n/a n/a
2020-02-14 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 188,700 55.05 11,969 248.95 n/a n/a n/a
2019-11-14 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 121,700 50.99 3,430 60.58 n/a n/a n/a
2019-08-14 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 80,600 37.07 2,136 97.96 n/a n/a n/a
2019-05-15 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 58,800 4.81 1,079 54.81 n/a n/a n/a
2019-02-14 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 56,100 -45.11 697 -64.42 n/a n/a n/a
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 102,200 92.11 1,959 170.58 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Call 53,200 75.58 724 232.11 n/a n/a n/a
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 53,200 724 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Call 30,300 -32.37 218 32.12 n/a n/a n/a
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 30,300 218 n/a n/a n/a
2018-02-09 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 44,800 70.99 165 46.02 n/a n/a n/a
2017-11-09 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 26,200 -8.07 113 145.65 n/a n/a n/a
2017-08-11 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 28,500 77.02 46 53.33 n/a n/a n/a
2017-05-12 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 16,100 -55.77 30 -46.43 n/a n/a n/a
2017-02-10 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Call 36,400 53.59 56 -67.82 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Call 23,700 -24.28 174 4.19 n/a n/a n/a
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS Cmn Call 23,700 174 n/a n/a n/a
2017-01-31 2016-06-30 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Call 31,300 167 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS Cmn Call 31,300 167 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 65,300 -2.10 4,094 -7.54 n/a n/a n/a
2026-02-17 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 66,700 2.62 4,428 97.59 n/a n/a n/a
2025-11-14 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 65,000 -65.28 2,242 -24.21 n/a n/a n/a
2025-08-14 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 187,200 28.22 2,958 58.98 n/a n/a n/a
2025-05-15 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 146,000 8.55 1,860 -26.42 n/a n/a n/a
2025-02-14 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 134,500 65.23 2,529 60.41 n/a n/a n/a
2024-11-14 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 81,400 14.01 1,577 -15.04 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 71,400 32.96 1,856 20.85 n/a n/a n/a
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 53,700 1.51 1,536 -5.13 n/a n/a n/a
2024-02-14 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 52,900 55.59 1,619 77.22 n/a n/a n/a
2023-11-14 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 34,000 -25.11 914 -43.57 n/a n/a n/a
2023-08-14 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 45,400 22.70 1,619 72.31 n/a n/a n/a
2023-05-15 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 37,000 -54.71 940 -71.66 n/a n/a n/a
2023-02-14 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 81,700 -5.66 3,314 15.76 n/a n/a n/a
2022-11-14 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 86,600 0.46 2,862 -5.70 n/a n/a n/a
2022-08-15 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 86,200 -1.82 3,035 -24.84 n/a n/a n/a
2022-05-16 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 87,800 -15.33 4,038 -41.27 n/a n/a n/a
2022-02-14 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 103,700 -26.71 6,875 -22.18 n/a n/a n/a
2021-11-15 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 141,500 -10.89 8,834 -32.83 n/a n/a n/a
2021-08-16 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 158,800 50.09 13,152 87.46 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN COM Put 105,800 -8.48 7,016 -20.90 n/a n/a n/a
2021-05-17 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 105,800 7,016 n/a n/a n/a
2021-02-16 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM Put 115,600 -30.65 8,870 23.57 n/a n/a n/a
2020-11-16 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM Put 166,700 -0.83 7,178 -1.13 n/a n/a n/a
2020-08-14 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 168,100 12.44 7,260 68.80 n/a n/a n/a
2020-05-15 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 149,500 -3.36 4,301 -56.17 n/a n/a n/a
2020-02-14 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 154,700 67.97 9,813 278.15 n/a n/a n/a
2019-11-14 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 92,100 22.47 2,595 30.21 n/a n/a n/a
2019-08-14 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 75,200 134.27 1,993 238.37 n/a n/a n/a
2019-05-15 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 32,100 -70.19 589 -55.98 n/a n/a n/a
2019-02-14 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 107,700 9.67 1,338 -28.91 n/a n/a n/a
2018-11-13 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 98,200 42.11 1,882 100.21 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Put 69,100 111.96 940 300.00 n/a n/a n/a
2018-08-10 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 69,100 940 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Put 32,600 64.65 235 221.92 n/a n/a n/a
2018-05-11 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 32,600 235 n/a n/a n/a
2018-02-09 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 19,800 81.65 73 55.32 n/a n/a n/a
2017-11-09 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 10,900 47 n/a n/a n/a
2017-05-12 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN Cmn Put 13,700 -42.19 21 -87.93 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN Cmn Put 23,700 174 n/a n/a n/a
2016-11-10 2016-09-30 13F ARROWHEAD PHARMACEUTICALS Cmn Put 23,700 174 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.